Pharmaceuticals, Biotechnology and Life Sciences
Boehringer Ingelheim Pharmaceuticals has gotten an approval from the FDA, for a broadened indication of its afatinib for patients with…
Evgen Pharma, a clinical stage drug development company focused on cancer and neurological conditions, will showcase the results of mechanistic…
TiGenix’s result from study of Xx601 treatment for Chron’s disease has also been published in one of the leading scientific…
The European Commission (EC) has given Shire’s ADYNOVI a green light as an extended half-life recombinant factor VIII (rFVIII) treatment…
Hikma Pharmaceuticals will add Surendera Tyagi as Group Chief Scientific Officer and Global Head of Research and Development, who will…
Sinclair pharma has reported revenue growth in excess of 80% over the last two years will, as expected, return the…
The FDA has expanded the use of AstraZeneca’s Lynparza, the treatment for certain types of breast cancer patients, making it the…
Teva and AlderBiopharmaceuticals have entered into a European patent settlement and global license agreement with Teva Pharmaceuticals International GmbH, the new subsidiary of Teva Pharmaceutical Industries.
The agreement resolves Alder’s appeal following
The U.S. Food and Drug Administration said Thursday it has warned Becton Dickinson (BD) about several violations of federal law. BD…
Novartis has appointed Elizabeth Barrett, currently Global President Oncology at Pfizer, Inc., as the CEO Novartis Oncology and a member…